Literature DB >> 9013475

Burkitt-like blast crisis in chronic myeloid leukemia.

M Colovic1, G Jankovic, V Lazarevic, V Lazrevic.   

Abstract

A case of Burkitt-like blast crisis in a patient with chronic myelocytic leukaemia (CML) is presented. To our knowledge, this is the first such case recorded to date. The patient had a useful response to combination chemotherapy.

Entities:  

Mesh：

Year:  1996        PMID： 9013475     DOI： 10.1007/bf02993862

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


  5 in total

1.  Immunophenotypic, genomic and clinical characteristics of blast crisis of chronic myelogenous leukaemia.

Authors:  J M Hernández; R González-Sarmiento; C Martin; M González; I Sánchez; J Corral; A Orfao; M C Cañizo; J F San Miguel; A López-Borrasca
Journal:  Br J Haematol       Date:  1991-11       Impact factor: 6.998

2.  Characterisation of blast cells during blastic phase of chronic myeloid leukaemia by immunophenotyping--experience in 60 patients.

Authors:  T Saikia; S Advani; A Dasgupta; G Ramakrishnan; C Nair; B Gladstone; M S Kumar; Y Badrinath; S Dhond
Journal:  Leuk Res       Date:  1988       Impact factor: 3.156

3.  Cell lineage heterogeneity in blast crisis of chronic myeloid leukaemia.

Authors:  P Bettelheim; D Lutz; O Majdic; E Paietta; O Haas; W Linkesch; E Neumann; K Lechner; W Knapp
Journal:  Br J Haematol       Date:  1985-03       Impact factor: 6.998

4.  Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia.

Authors:  D Fière; E Lepage; C Sebban; C Boucheix; C Gisselbrecht; J P Vernant; B Varet; A Broustet; J Y Cahn; F Rigal-Huguet
Journal:  J Clin Oncol       Date:  1993-10       Impact factor: 44.544

5.  Immunophenotypic characteristics of blast crisis of chronic myeloid leukaemia: correlations with clinico-biological features and survival.

Authors:  A Urbano-Ispizua; F Cervantes; E Matutes; N Villamor; A Pujades; J Sierra; E Feliu; J L Vives-Corrons; E Montserrat; C Rozman
Journal:  Leukemia       Date:  1993-09       Impact factor: 11.528
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.